← Back to Search

Corneal Inlay

Raindrop for Presbyopia

Phase 3
Waitlist Available
Research Sponsored by ReVision Optics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

The objective of this study is to evaluate the safety and effectiveness of the Raindrop Near Vision Inlay implanted in bilateral pseudophakes with presbyopia for improvement of near and intermediate vision.

Eligible Conditions
  • Presbyopia
  • Pseudophakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in uncorrected near visual acuity
Preservation of best corrected visual acuity
Secondary outcome measures
Adverse Events
Improvement in uncorrected intermediate visual acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: RaindropExperimental Treatment1 Intervention
A single arm study to evaluate the effectiveness of a 2mm Raindrop Near Vision Inlay for the treatment of presbyopia in pseudophakic subjects. This corneal inlay is placed under a LASIK flap or in a corneal pocket, and is designed to change the anterior curvature of the cornea, resulting in the ability to reduce spectacle dependency for near and intermediate tasks.

Find a Location

Who is running the clinical trial?

ReVision Optics, Inc.Lead Sponsor
2 Previous Clinical Trials
386 Total Patients Enrolled
2 Trials studying Presbyopia
386 Patients Enrolled for Presbyopia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~43 spots leftby Apr 2025